Kalyra Pharmaceuticals

OverviewSuggest Edit

Kalyra Pharmaceuticals is a company developing non-opioid, non-NSAID (nonsteroidal anti-inflammatory drug) pain therapeutics. It creates products that can be used alone and in combination with other analgesic classes to treat moderate to severe pain without the potential for addiction or abuse.
TypePrivate
Founded2012
Websitekalyrapharma.com

Latest Updates

Employees (est.) (Jun 2019)17(-5%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Kalyra Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2012

Kalyra Pharmaceuticals total Funding

$6 m

Kalyra Pharmaceuticals latest funding size

$6 m

Time since last funding

8 years ago

Kalyra Pharmaceuticals investors

Kalyra Pharmaceuticals's latest funding round in August 2013 was reported to be $6 m. In total, Kalyra Pharmaceuticals has raised $6 m
Show all financial metrics

Kalyra Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

Kalyra Pharmaceuticals Online and Social Media Presence

Embed Graph

Kalyra Pharmaceuticals Frequently Asked Questions

  • When was Kalyra Pharmaceuticals founded?

    Kalyra Pharmaceuticals was founded in 2012.

  • How many employees does Kalyra Pharmaceuticals have?

    Kalyra Pharmaceuticals has 17 employees.

  • Who are Kalyra Pharmaceuticals competitors?

    Competitors of Kalyra Pharmaceuticals include Cellarity, Origene Technologies and Bioiberica.